Skip to main content

CRISPR Therapeutics

Cambridge, United States

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

$550.0M raised
Mar 2026
Post-IPO Debt

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CRISPR Therapeutics

How much funding has CRISPR Therapeutics raised?
CRISPR Therapeutics has raised $550.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in March 2026.
Who are CRISPR Therapeutics's investors?
CRISPR Therapeutics's investors include Franklin Templeton, Bill & Melinda Gates Foundation, New Enterprise Associates, Versant Ventures, Abingworth.
Where is CRISPR Therapeutics headquartered?
CRISPR Therapeutics is headquartered in Cambridge, United States.
What does CRISPR Therapeutics do?
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
What stage is CRISPR Therapeutics at?
CRISPR Therapeutics is at the Post-IPO Debt stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"CRISPR Therapeutics — Funding & Investors." VCBacked, March 11, 2026, https://www.vcbacked.co/company/crispr-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2026). CRISPR Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/crispr-therapeutics
Wikipedia (cite web)
{{cite web |title=CRISPR Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/crispr-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .